In Brief: Miles' Mezlin
Executive Summary
Miles' Mezlin: Recalls 29 lots of sterile mezlocillin sodium due to "a typographical error in package insert labeling," the company announces March 1. Wholesalers and all U.S. nephrologists are receiving notice of the recall. The labeling for the 10,000 10-pack units of intramuscular or intravenous vials and infusion bottles "erroneously recommends that patients with impaired renal function undergoing peritoneal dialysis may receive three grams every two hours," Miles states. The actual dosing is three grams every 12 hours. Miles "has received no reports of injuries" associated with erroneously labeled Mezlin, in use since 1991, the company says...